Current Status of the Treatment of COPD in China: A Multicenter Prospective Observational Study

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. 2017 Available from: http://goldcopd.org. Accessed 121, 2016.
   Google Scholar
• WangC, XuJ, YangL, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-929650248
   PubMed Web of Science ®Google Scholar
• TashkinDP, CooperCB. The role of long-acting bronchodilators in the management of stable COPD. Chest. 2004;125(1):249–259. doi:10.1378/chest.125.1.24914718448
   PubMed Web of Science ®Google Scholar
• MiravitllesM. Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J. 2002;20(1):243–244. doi:10.1183/09031936.02.0130200112166576
   PubMed Web of Science ®Google Scholar
• Riario-SforzaGG, IncorvaiaC, PravettoniC, DugnaniN. Guidelines versus clinical practice in the treatment of COPD: a reappraisal. Eur Respir J. 2006;27(3):656. doi:10.1183/09031936.06.0012010516507872
   PubMed Web of Science ®Google Scholar
• CorradoA, RossiA. How far is real life from COPD therapy guidelines? An Italian observational study. Respir Med. 2012;106(7):989–997. doi:10.1016/j.rmed.2012.03.00822483189
   PubMed Web of Science ®Google Scholar
• SimeoneJC, LuthraR, KailaS, et al. Initiation of triple therapy maintenance treatment among patients with COPD in the US. Int J Chron Obstruct Pulmon Dis. 2017;12:73–83. doi:10.2147/COPD.S12201328053518
   PubMed Web of Science ®Google Scholar
• PriceD, WestD, BrusselleG, et al. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns. Int J Chron Obstruct Pulmon Dis. 2014;9:889–904. doi:10.2147/COPD.S6275025210450
   PubMed Web of Science ®Google Scholar
• ChanKK, KoF, ChanHS, et al. Adherence to a COPD treatment guideline among patients in Hong Kong. Int J Chron Obstruct Pulmon Dis. 2017;12:3371–3379. doi:10.2147/COPD.S14707029238182
   PubMed Web of Science ®Google Scholar
• Y HC, W ZY, KangJ, et al. Attitudes and actions of chronic obstructive pulmonary disease patients on treatment: a national multi-center investigative study. Zhonghua Jie He He Hu Xi Za Zhi. 2010;33(10):750–753.21176506
   PubMedGoogle Scholar
• International Classification of Diseases. Clinical modification tenth revision. Available from: http://apps.who.int/classifications/icd10/browse/2016/en#/J43. Accessed 121, 2016.
   Google Scholar
• ThabaneM, GroupCW. Smoking cessation for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis. Ont Health Technol Assess Ser. 2012;12(4):1–50.
   Google Scholar
• MillerMR, HankinsonJ, BrusascoV, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.0003480516055882
   PubMed Web of Science ®Google Scholar
• WedzichaJA, SeemungalTA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-817765528
   PubMed Web of Science ®Google Scholar
• QuintJK, DonaldsonGC, HurstJR, GoldringJJ, SeemungalTR, WedzichaJA. Predictive accuracy of patient-reported exacerbation frequency in COPD. Eur Respir J. 2011;37(3):501–507. doi:10.1183/09031936.0003590920650988
   PubMed Web of Science ®Google Scholar
• DingB, SmallM, ScheffelG, HolmgrenU. Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care. Int J Chron Obstruct Pulmon Dis. 2018;13:927–936. doi:10.2147/COPD.S15452529588581
   PubMed Web of Science ®Google Scholar
• GreweFA, SieviNA, BradicichM, et al. Compliance of pharmacotherapy with GOLD guidelines: a longitudinal study in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:627–635. doi:10.2147/COPD.S24044432273691
   PubMed Web of Science ®Google Scholar
• TuranO, EmreJC, DenizS, BaysakA, TuranPA, MiriciA. Adherence to current COPD guidelines in Turkey. Expert Opin Pharmacother. 2016;17(2):153–158. doi:10.1517/14656566.2016.111548226629809
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. 2014 Available from: http://goldcopd.org. Accessed 1024, 2018.
   Google Scholar
• RamFS, JonesPW, CastroAA, et al. Oral theophylline for chronic obstructive pulmonary disease (Review). Cochrane Database Syst Rev. 2002;4:CD003902.
   PubMedGoogle Scholar
• DevereuxG, CottonS, FieldingS, et al. Effect of theophylline as adjunct to inhaled corticosteroids on exacerbations in patients with COPD: a randomized clinical trial. JAMA. 2018;320(15):1548–1559. doi:10.1001/jama.2018.1443230326124
   PubMed Web of Science ®Google Scholar
• KidaK, MotegiT, IshiiT, HattoriK. Long-term oxygen therapy in Japan: history, present status, and current problems. Pneumonol Alergol Pol. 2013;81(5):468–478.23996887
   PubMedGoogle Scholar
• BransonRD. Oxygen therapy in COPD. Respir Care. 2018;63(6):734–748. doi:10.4187/respcare.0631229794207
   PubMed Web of Science ®Google Scholar
• LiaoH, PeiW, LiH, et al. Efficacy of long-term noninvasive positive pressure ventilation in stable hypercapnic COPD patients with respiratory failure: a meta-analysis of randomized controlled trials. Int J Chron Obstruct Pulmon Dis. 2017;12:2977–2985. doi:10.2147/COPD.S14842229066879
   PubMed Web of Science ®Google Scholar
• JacksonLA, GurtmanA, van CleeffM, et al. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older. Vaccine. 2013;31(35):3594–3602. doi:10.1016/j.vaccine.2013.04.08423688525
   PubMed Web of Science ®Google Scholar
• HsuDJ, NorthCM, BrodeSK, CelliBR. Identification of barriers to influenza vaccination in patients with chronic obstructive pulmonary disease: analysis of the 2012 behavioral risk factors surveillance system. Chronic Obstr Pulm Dis. 2016;3(3):620–627.27981230
   PubMedGoogle Scholar
• LallD, CasonE, PasquelFJ, AliMK, NarayanKM. Effectiveness of influenza vaccination for individuals with chronic obstructive pulmonary disease (COPD) in low- and middle-income countries. COPD. 2016;13(1):93–99. doi:10.3109/15412555.2015.104351826418892
   PubMedGoogle Scholar
• CampPG, HernandezP, BourbeauJ, et al. Pulmonary rehabilitation in Canada: a report from the Canadian Thoracic Society COPD Clinical Assembly. Can Respir J. 2015;22(3):147–152. doi:10.1155/2015/36985125848802
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare. Monitoring pulmonary rehabilitation and long-term oxygen therapy for people with chronic obstructive pulmonary disease (COPD) in Australia: a discussion paper. 2013 Available from: https://www.aihw.gov.au/. Accessed 1025, 2020.
   Google Scholar
• ChenY-J, FanJ-Y, GuoS-E, HwangSL, YangTM. Factors facilitating and hindering the intention to promote pulmonary rehabilitation for patients with COPD among respiratory therapists. Int J Chron Obstruct Pulmon Dis. 2017;12:2695–2702. doi:10.2147/COPD.S14212428979111
   PubMed Web of Science ®Google Scholar
• SohanpalR, SteedL, MarsT, TaylorSJ. Understanding patient participation behaviour in studies of COPD support programmes such as pulmonary rehabilitation and self-management: a qualitative synthesis with application of theory. NPJ Prim Care Respir Med. 2015;25:15054. doi:10.1038/npjpcrm.2015.5426379121
   PubMed Web of Science ®Google Scholar
• SiddiquiFM, DiamondJM. Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions. Curr Opin Pulm Med. 2018;24(2):199–204. doi:10.1097/MCP.000000000000045229227305
   PubMed Web of Science ®Google Scholar
• BogartM, StanfordRH, LalibertéF, GermainG, WuJW, DuhMS. Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population. Int J Chron Obstruct Pulmon Dis. 2019;14:343–352. doi:10.2147/COPD.S18465330863037
   PubMed Web of Science ®Google Scholar
• TøttenborgSS, LangeP, JohnsenSP, NielsenH, IngebrigtsenTS, ThomsenRW. Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPD. Respir Med. 2016;119:160–167. doi:10.1016/j.rmed.2016.09.00727692139
   PubMed Web of Science ®Google Scholar
• CalzettaL, CazzolaM, MateraMG, RoglianiP. Adding a LAMA to ICS/LABA therapy: a meta-analysis of triple combination therapy in COPD. Chest. 2019;155(4):758–770. doi:10.1016/j.chest.2018.12.01630660781
   PubMed Web of Science ®Google Scholar
• SuissaS, Dell’AnielloS, ErnstP. Comparative effectiveness and safety of LABA-LAMA vs LABA-ICS treatment of COPD in real-world clinical practice. Chest. 2019;155(6):1158–1165. doi:10.1016/j.chest.2019.03.00530922950
   PubMed Web of Science ®Google Scholar
• RabeKF, MartinezFJ, FergusonGT, et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N Engl J Med. 2020;383(1):35–48. doi:10.1056/NEJMoa191604632579807
   PubMed Web of Science ®Google Scholar
• LangeP, CelliB, AgustiA, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med. 2015;373(2):111–122.26154786
   PubMed Web of Science ®Google Scholar
• KarampitsakosT, HillasG, ZervasE, et al. Prospective evAluatIon foR inhalation devices in Greek patients with COPD and asthma: the PAIR study. Pulm Pharmacol Ther. 2020;60:101882. doi:10.1016/j.pupt.2019.10188231881275
   PubMed Web of Science ®Google Scholar